Nanexa files a new patent application
Nanexa files a new patent application
Nanexa strengthens its patent portfolio by filing a further patent application to the UK Patent Office. The patent application relates to an invention linked to Nanexa’s drug delivery system PharmaShell®.
New animal study shows additional benefits with PharmaShell®
Uppsala 6th November 2017
New animal study shows additional benefits with PharmaShell®
In Nanexa’s ongoing animal study, the first results have shown that the further development of the PharmaShell® technology significantly reduces the initial concentration peak.
